賽諾醫療(688108.SH):顱內自膨藥物支架目前處於臨牀隨訪階段,預計於2023年提交創新審批
格隆匯5月29日丨賽諾醫療(688108.SH)於2023年5月19日、5月22日-5月24日、5月26日接受機構現場參觀或參與投資者交流,互動交流環節中,就“顱內自膨藥物支架作為公司即將上市的一款重磅產品,請問目前研發的進展如何?”,公司回覆稱,該產品是繼公司NOVA顱內藥物洗脱支架系統上市後,國際上首個進入臨牀試驗階段的自膨式顱內藥物洗脱支架系統,將與公司現有的NOVA顱內藥物洗脱支架系統形成有效互補。該產品具有規格型號豐富,支撐力更強,順行性優、操作性更強等特點。2023年2月完成全部臨牀入組工作,目前處於臨牀隨訪階段,預計於2023年提交創新審批,2024年上半年能夠上市銷售。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.